LEIDOS BIOMEDICAL RESEARCH, INC.
MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE
MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE is a funding opportunity from LEIDOS BIOMEDICAL RESEARCH, INC., up to 61516, closing September 14, 2026.
Sep 14, 2026
(45d left)Overview
The scope of this contract is for generating a 2 Kg GMP batch of Hydroxocobalamin (OHCbl). The contractor shall provide the Certificate of Analysis (COA), a Quality Overall Summary (Module 2.3.S) or a DMF file number, and material safety data sheet.